PBS Website Update - 1 August 2024
Page last updated: 1 August 2024
The Schedule of Pharmaceutical Benefits was updated on 1 August 2024. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Xolair® (omalizumab) PBS pricing information - 1 August 2024
- Advance notice of 1 February 2025 change in Authority level for saxagliptin with dapagliflozin (Qtern® 5/10) - 1 August 2024
- Ex-manufacturer price - 1 August 2024
- Formulary Allocations - 1 August 2024
- Anniversary Price Reductions - 1 August 2024
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 August 2024
- Medicine Status Website - 1 August 2024
- Drug Tariff - 1 August 2024
- Standard Formula Preparations - 1 August 2024
- Container Prices - 1 August 2024
- Container Prices, Fees, Standard Packs and Prices for Ready Prepared Pharmaceutical Benefits - 1 August 2024
- Agenda for the November 2024 PBAC meeting – 31 July 2024
- Community Pharmacy Agreements - 23 July 2024
- PBAC Public Summary Documents – March 2024 meeting (first time decisions not to recommend and deferrals) - 19 July 2024
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 19 July 2024
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 19 July 2024
- PBS and RPBS Section 85 Date of Supply Data - 19 July 2024
- Cost Recovery Fees and Charges - 19 July 2024
- Current Price Disclosure cycle – 2024 October - 18 July 2024
- Updates to the HTA Policy and Methods Review - 10 July 2024
- Post-market Review workplan (May 2024) published - 8 July 2024
- PBAC Public Summary Documents – March 2024 meeting - 5 July 2024
- Expansion of the CTG PBS Co-Payment Program - 1 July 2024
